# Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia

> **NCT00434616** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Franziskus-Krankenhaus** · enrollment: 90 (estimated)

## Conditions studied

- Peripheral Vascular Disease
- Diabetic Foot
- Peripheral Arterial Occlusive Disease
- Leg Ulcer
- Gangrene
- Ischemia

## Interventions

- **PROCEDURE:** Autologous bone marrow cell concentrate transplantation
- **BIOLOGICAL:** saline injection

## Key facts

- **NCT ID:** NCT00434616
- **Lead sponsor:** Franziskus-Krankenhaus
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2011-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434616, "Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00434616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*